BB Biotech AG is a Switzerland-based investment company specializing in the biotechnology sector. Its principal activity involves investing in fast-growing biotechnology companies developing and comme... BB Biotech AG is a Switzerland-based investment company specializing in the biotechnology sector. Its principal activity involves investing in fast-growing biotechnology companies developing and commercializing innovative drugs that address significant unmet medical needs, particularly in areas like oncology, infectious diseases, cardiovascular and metabolic disorders, autoimmune diseases, neurological disorders, and emerging technologies such as cell, gene, and RNA-based therapies. The portfolio typically comprises 20 to 35 companies, with a focus on small- to mid-cap firms primarily in the United States and Western Europe, alongside select large-cap holdings; core investments as of late 2024 included Argenx, Ionis Pharmaceuticals, Neurocrine Biosciences, and Vertex Pharmaceuticals. Managed by Bellevue Asset Management AG since its founding in 1993 and headquartered in Schaffhausen, BB Biotech AG provides investors access to this high-growth industry through a diversified, long-only strategy emphasizing fundamental analysis and companies with promising pipelines nearing commercialization. With over 30 years of experience, it stands as one of the world's largest biotech-focused investors, supporting advancements in healthcare efficiency and novel treatments.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

BB Biotech is not subject to EU Taxonomy reporting

Based on current regulatory requirements, BB Biotech is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review BB Biotech's data?

Start your 30-day free trial to request a data review for BB Biotech.

Start Free Trial

Legal Center Contact Us